NO20000579L - Heparin-bindende vekstfaktor (HBGF) -polypeptider - Google Patents
Heparin-bindende vekstfaktor (HBGF) -polypeptiderInfo
- Publication number
- NO20000579L NO20000579L NO20000579A NO20000579A NO20000579L NO 20000579 L NO20000579 L NO 20000579L NO 20000579 A NO20000579 A NO 20000579A NO 20000579 A NO20000579 A NO 20000579A NO 20000579 L NO20000579 L NO 20000579L
- Authority
- NO
- Norway
- Prior art keywords
- polypeptides
- hbgf
- growth factor
- heparin
- hbgfs
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/85—Reproductive organs or embryos
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Vascular Medicine (AREA)
- Dermatology (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/908,526 US5876730A (en) | 1997-08-07 | 1997-08-07 | Heparin-binding growth factor (HBGF) polypeptides |
PCT/US1998/016423 WO1999007407A1 (en) | 1997-08-07 | 1998-08-06 | Heparin-binding growth factor (hbgf) polypeptides |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20000579D0 NO20000579D0 (no) | 2000-02-04 |
NO20000579L true NO20000579L (no) | 2000-02-25 |
Family
ID=25425931
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20000579A NO20000579L (no) | 1997-08-07 | 2000-02-04 | Heparin-bindende vekstfaktor (HBGF) -polypeptider |
Country Status (15)
Country | Link |
---|---|
US (3) | US5876730A (pt) |
EP (1) | EP1003545B1 (pt) |
JP (2) | JP4638027B2 (pt) |
CN (1) | CN1276729A (pt) |
AT (1) | ATE395927T1 (pt) |
AU (1) | AU744585B2 (pt) |
BR (1) | BR9811861A (pt) |
CA (1) | CA2299411A1 (pt) |
DE (1) | DE69839516D1 (pt) |
DK (1) | DK1003545T3 (pt) |
ES (1) | ES2307322T3 (pt) |
IL (1) | IL134330A0 (pt) |
NO (1) | NO20000579L (pt) |
PT (1) | PT1003545E (pt) |
WO (1) | WO1999007407A1 (pt) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6562618B1 (en) | 1997-12-25 | 2003-05-13 | Japan Tobacco, Inc. | Monoclonal antibody against connective tissue growth factor and medicinal uses thereof |
CA2346406C (en) * | 1998-10-06 | 2009-02-17 | Anton Wellstein | Detection of pleiotrophin |
US7141384B1 (en) | 1998-10-06 | 2006-11-28 | Georgetown University | Detection of pleiotrophin |
JP4722290B2 (ja) * | 1998-12-14 | 2011-07-13 | ユニバーシティー オブ マイアミ | 結合組織成長因子(ctgf)断片とそれを用いた方法および使用 |
US7115390B1 (en) * | 1998-12-14 | 2006-10-03 | Fibrogen, Inc. | Connective tissue growth factor fragments and methods and uses thereof |
AU2001288392A1 (en) | 2000-08-30 | 2002-03-13 | University Of Delaware | Delivery system for heparin-binding growth factors |
US7297343B2 (en) * | 2001-07-31 | 2007-11-20 | Biosurface Engineering Technologies, Inc. | Bioactive medical films |
FR2828104B1 (fr) * | 2001-08-01 | 2005-06-24 | Chu Montpellier | Utilisation d'inhibiteurs du facteur de croissance epidermique liant l'heparine ou d'inhibiteurs de ses recepteurs pour la preparation de medicaments utiles pour traiter le myelome |
US20030113816A1 (en) * | 2001-09-18 | 2003-06-19 | Weitz Stephen L. | Methods of assaying connective tissue growth factor |
US6965025B2 (en) | 2001-12-10 | 2005-11-15 | Isis Pharmaceuticals, Inc. | Antisense modulation of connective tissue growth factor expression |
GB0225197D0 (en) * | 2002-10-30 | 2002-12-11 | Univ Sheffield | Surface |
US7405274B2 (en) | 2003-06-04 | 2008-07-29 | Fibrogen, Inc. | Connective tissue growth factor antibodies |
WO2005033136A1 (en) * | 2003-09-29 | 2005-04-14 | Children's Hospital, Inc. | Unique integrin binding site in connective tissue growth factor (ctgf) |
CN101884789A (zh) | 2004-02-11 | 2010-11-17 | 法布罗根股份有限公司 | Ctgf作为糖尿病肾病的治疗靶点 |
CA2565070A1 (en) | 2004-04-28 | 2005-11-24 | Fibrogen, Inc. | Anti-ctgf agents for the treatment of pancreatic cancer |
DE102004021872B3 (de) | 2004-05-04 | 2005-12-22 | Infineon Technologies Ag | Chipkarte, Verfahren zum Herstellen einer Chipkarte und elektrisch leitfähiges Kontaktierungselement |
US20070049739A1 (en) * | 2005-08-30 | 2007-03-01 | Biomet Manufacturing Corp. | Method and system for extracting blood-derived growth factors |
US8946172B2 (en) * | 2008-08-25 | 2015-02-03 | Excaliard Pharmaceuticals, Inc. | Method for reducing scarring during wound healing using antisense compounds directed to CTGF |
MX2011002143A (es) | 2008-08-25 | 2011-07-20 | Excaliard Pharmaceuticals Inc | Oligonucleotidos antisentido dirigidos contra el factor de crecimiento del tejido conectivo y usos de los mismos. |
CN101497656B (zh) * | 2009-03-09 | 2012-08-15 | 东南大学 | 与整合素αvβ3具有高结合活性的多肽及其应用 |
CN102666587A (zh) | 2009-07-02 | 2012-09-12 | 菲布罗根有限公司 | 用于治疗肌营养不良的方法 |
US9102721B2 (en) | 2011-01-21 | 2015-08-11 | Fibrogen, Inc. | Therapeutic method |
MX365647B (es) | 2011-02-02 | 2019-06-10 | Excaliard Pharmaceuticals Inc | El uso de compuestos antisentido dirigidos al factor de crecimiento del tejido conectivo (ctgf) para tratar queloides o cicatrices hipertroficas. |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5235042A (en) * | 1984-02-29 | 1993-08-10 | The Children's Medical Center Corporation | Endothelial cell growth factor |
US4868113A (en) * | 1986-03-03 | 1989-09-19 | Rorer Biotechnology, Inc. | Recombinant DNA vector encoding human endothelial cell growth factor |
US4946778A (en) * | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
IL85018A0 (en) * | 1988-01-03 | 1988-06-30 | Orgenics Ltd | Stable chromogenic substrate mixture of indoxyl phosphate and tetrazolium salt,method of making and using same in biological and diagnostic assays |
US5225326A (en) * | 1988-08-31 | 1993-07-06 | Research Development Foundation | One step in situ hybridization assay |
JPH06502538A (ja) | 1990-10-16 | 1994-03-24 | ザ チルドレンズメディカルセンターコーポレーション | 上皮細胞成長因子(egf)との相同性をもつヘパリン結合性マイトジェン |
US5408040A (en) * | 1991-08-30 | 1995-04-18 | University Of South Florida | Connective tissue growth factor(CTGF) |
US5770209A (en) | 1991-08-30 | 1998-06-23 | University Of South Florida | Acceleration of wound healing using connective tissue growth factor |
US5474796A (en) * | 1991-09-04 | 1995-12-12 | Protogene Laboratories, Inc. | Method and apparatus for conducting an array of chemical reactions on a support surface |
US5565332A (en) * | 1991-09-23 | 1996-10-15 | Medical Research Council | Production of chimeric antibodies - a combinatorial approach |
US5596090A (en) * | 1992-07-24 | 1997-01-21 | The United States Of America As Represented By The Secretary Of The Navy | Antisense oligonucleotides directed against human VCAM-1 RNA |
JPH10502534A (ja) | 1994-07-12 | 1998-03-10 | ヒューマン・ジェノム・サイエンシズ・インコーポレイテッド | 結合組織増殖因子−2 |
US5646115A (en) * | 1994-10-07 | 1997-07-08 | Heska Corporation | Ectoparasite saliva proteins and apparatus to collect such proteins |
US5607918A (en) * | 1995-03-01 | 1997-03-04 | Ludwig Institute For Cancer Research | Vascular endothelial growth factor-B and DNA coding therefor |
US5789389A (en) * | 1995-03-17 | 1998-08-04 | Board Of Trustees Of University Of Illinois | BCL2 derived genetic elements associated with sensitivity to chemotherapeutic drugs |
US7115390B1 (en) * | 1998-12-14 | 2006-10-03 | Fibrogen, Inc. | Connective tissue growth factor fragments and methods and uses thereof |
-
1997
- 1997-08-07 US US08/908,526 patent/US5876730A/en not_active Expired - Lifetime
-
1998
- 1998-07-09 US US09/113,924 patent/US7897732B2/en not_active Expired - Fee Related
- 1998-08-06 BR BR9811861-7A patent/BR9811861A/pt not_active IP Right Cessation
- 1998-08-06 JP JP2000506996A patent/JP4638027B2/ja not_active Expired - Lifetime
- 1998-08-06 AU AU86962/98A patent/AU744585B2/en not_active Ceased
- 1998-08-06 DE DE69839516T patent/DE69839516D1/de not_active Expired - Lifetime
- 1998-08-06 AT AT98938435T patent/ATE395927T1/de active
- 1998-08-06 WO PCT/US1998/016423 patent/WO1999007407A1/en active IP Right Grant
- 1998-08-06 CA CA002299411A patent/CA2299411A1/en not_active Abandoned
- 1998-08-06 IL IL13433098A patent/IL134330A0/xx unknown
- 1998-08-06 CN CN98809911A patent/CN1276729A/zh active Pending
- 1998-08-06 PT PT98938435T patent/PT1003545E/pt unknown
- 1998-08-06 EP EP98938435A patent/EP1003545B1/en not_active Expired - Lifetime
- 1998-08-06 DK DK98938435T patent/DK1003545T3/da active
- 1998-08-06 ES ES98938435T patent/ES2307322T3/es not_active Expired - Lifetime
-
2000
- 2000-02-04 NO NO20000579A patent/NO20000579L/no not_active Application Discontinuation
-
2009
- 2009-06-17 JP JP2009144424A patent/JP2009254370A/ja active Pending
-
2011
- 2011-02-28 US US13/037,219 patent/US20110160445A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU744585B2 (en) | 2002-02-28 |
US20110160445A1 (en) | 2011-06-30 |
CN1276729A (zh) | 2000-12-13 |
AU8696298A (en) | 1999-03-01 |
WO1999007407A1 (en) | 1999-02-18 |
US7897732B2 (en) | 2011-03-01 |
DK1003545T3 (da) | 2008-08-25 |
JP4638027B2 (ja) | 2011-02-23 |
BR9811861A (pt) | 2000-08-15 |
JP2009254370A (ja) | 2009-11-05 |
JP2001513334A (ja) | 2001-09-04 |
EP1003545A1 (en) | 2000-05-31 |
US20010007019A1 (en) | 2001-07-05 |
EP1003545B1 (en) | 2008-05-21 |
DE69839516D1 (de) | 2008-07-03 |
CA2299411A1 (en) | 1999-02-18 |
NO20000579D0 (no) | 2000-02-04 |
WO1999007407A9 (en) | 1999-05-06 |
EP1003545A4 (en) | 2002-03-06 |
ATE395927T1 (de) | 2008-06-15 |
PT1003545E (pt) | 2008-08-13 |
ES2307322T3 (es) | 2008-11-16 |
IL134330A0 (en) | 2001-04-30 |
US5876730A (en) | 1999-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20000579L (no) | Heparin-bindende vekstfaktor (HBGF) -polypeptider | |
NO995044L (no) | Osteoprotegerinbindende proteiner og reseptorer | |
MX9206315A (es) | Heterodimeros recombinantes de proteinas morfogenicas de hueso, composiciones de estos y metodos para su uso. | |
CY1107821T1 (el) | Πολυπεπτιδιο παραγοντα viii με ενεργοτητα παραγοντα viii:c | |
CY1112101T1 (el) | Νευροτροφικοι παραγοντες | |
NZ330897A (en) | Human trk receptors and neurotropic factor inhibitors | |
ME00185B (me) | Specifični agensi koji vezuju humani angiopoetin-2 | |
ATE265529T1 (de) | Bmp-10 zusammensetzungen | |
ATE234124T1 (de) | Verfahren zur herstellung von wirkstoffhaltigen knochenzementen | |
DE69032598D1 (de) | Zusammensetzungen und methoden zur synthese des b-rezeptors für das natriuretische protein und verwendungsmethoden | |
PT804562E (pt) | Factor 2 de crescimento de tecido conjuntivo | |
PT783521E (pt) | Compostos polipeptidos que contem d-2-alquiltriptofano capazes de promover a libertacao da hormona do crescimento | |
ATE107859T1 (de) | Verwendung von antiprogestomimetika zur stimulierung des eisprungs. | |
DE69533044D1 (de) | FÜR DEN TYP II-MORPHOGENETISCHEN-KNOCHENPROTEIN-REZEPTOR KODIERENDE cDNS | |
ATE263239T1 (de) | Produkte des keratinocyten-wachstumsfaktors 2 (kgf-2) | |
SE9602822D0 (sv) | New receptor | |
IL129139A0 (en) | Vertebrate smoothened proteins | |
DE69315989T2 (de) | Aminoterminale prokollagen 1(i) peptide | |
ATE293163T1 (de) | Cyclin e spezifische konstrukte und komplexe | |
DE59805246D1 (de) | Tissue-faktor zur beeinflussung von gefässbildung | |
SE9604439D0 (sv) | New receptor | |
ES2186501A1 (es) | Factor de crecimiento fibroblastico basico con un dominio de union especifico a colegeno. | |
EA200100110A1 (ru) | Нейротрофические факторы | |
DE59611353D1 (de) | Transketolase-verwandtes protein | |
ATE134989T1 (de) | N-trityl asparaginsäurederivate zur herstellung von phosphonat nmda antagonisten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |